Synagis

What is RSV?

RSV is found everywhere and highly contagious: approximately two-thirds of all infants are infected with RSV during the first year of life and almost 100% by the age of two. Most of these RSV infections cause minor upper respiratory illness and cold-like symptoms. However, in infants and children, RSV infection may cause serious lower respiratory tract disease. It has been estimated in some U.S. communities that between 50-80% of bronchiolitis hospitalizations from November through April are due to RSV disease. Nationwide, it has been estimated that RSV infection causes up to 125,000 hospitalizations annually with a 2% mortality rate.

Why Synagis can help?

Synagis (palivizumab) is the first monoclonal antibody successfully developed to combat this infectious disease. It is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high-risk of RSV disease. Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and infants with a history of prematurity (less than 35 weeks gestational age). Synagis is approved by the FDA. Synagis is administered as a monthly intramuscular (IM) injection during the RSV season, typically fall through spring, however, the season varies and Genesis At Home is prepared to meet your needs.

Who administers Synagis?

Synagis is administered in your home by one of our nurses or a nurse from an agency in you rlocal area. The nurse will administer a Synagis injection into your child’s thigh. Depending on your insurance coverage, Synagis injections will be given monthly beginning in October or November and run through the end of RSV season in the spring. To obtain optimal effectiveness of the product, It is important not to miss any injections and for the injections to be on time each month.

Who supplies Synagis?

University of Iowa Community HomeCare pharmacy will ship or deliver the synagis to your home at the time that the injection is due. You will be given a courtesy call from the pharmacy each month prior to delivery to alert you when your child's Synagis will be arriving. Synagis vials need to be stored in the refrigerator until your nurse arrives to administer the medication.

How does your child participate in the Synagis program?

Your physician needs to evaluate your child to determine a medical necessity for Synagis. If your child meets these qualifications, and with your physician’s referral, University of Iowa Community HomeCare will begin initiation of service for Synagis administration. Our Synagis team will coordinate your Synagis injections with your doctor, insurance company and nursing agency to provide for a smooth and uncomplicted service for you child.

For more information

Contact Synagis Cooordinator
University of Iowa Community HomeCare
2949 Sierra Ct SW, Iowa City, IA 52240
319-337-9382 or 888-262-6469 ext 2103